Antiretroviral therapy (ART) coverage in Angola for adult women living with HIV has shown a moderate but fluctuating upward trend over the past decade. In 2023, the coverage stood at 35. This figure represents a 6.06% increase year-over-year. It's noteworthy that since 2021, the year-on-year growth has averaged around 4.56%, signaling a steady improvement in ART coverage despite earlier years of variable growth. The compound annual growth rate (CAGR) over the last 5 years has been 4.56%, reflective of an ongoing yet gradual effort to improve healthcare access.
Looking ahead into the forecasted data from 2024 to 2028, the ART coverage is expected to experience a forecasted 5-year CAGR of 2.64%, amounting to a 13.89% overall growth rate. By 2028, the projected coverage is anticipated to reach 41. Although the growth rate is slower compared to previous years, this steady increase still indicates progress towards better ART accessibility.
Future trends to watch for include policy implementation aimed at boosting healthcare infrastructure, international aid contributions, and innovative approaches in HIV treatment. Close monitoring of these factors will be essential to ensure the continued expansion and effectiveness of ART programs in Angola.
